Showing results (121-130 of 198) with videos related to
Sort By:
Pageof 20
Metabolism: Clinical and Experimental|March 31, 2015
Glycated albumin as a diagnostic tool for diabetes in a general Japanese populationHiroaki Ikezaki, Norihiro Furusyo, Takeshi Ihara, et al.Journal of Clinical Lipidology|May 16, 2017
Cardiovascular disease prevalence and insulin resistance in the Kyushu-Okinawa Population Study and the Framingham Offspring StudyHiroaki Ikezaki, Masumi Ai, Ernst J Schaefer, et al.Scientific Reports|November 11, 2016
Ethnic Differences in Glucose Homeostasis Markers between the Kyushu-Okinawa Population Study and the Framingham Offspring StudyHiroaki Ikezaki, Masumi Ai, Ernst J Schaefer, et al.Journal of Dermatological Science|August 6, 2019
Serum squamous cell carcinoma antigen (SCCA)-2 correlates with clinical severity of pediatric atopic dermatitis in Ishigaki cohortSatoshi Takeuchi, Norihiro Furusyo, Junya Ono, et al.Journal of Gastroenterology and Hepatology|June 23, 2015
Comparative effectiveness and safety study of triple therapy with simeprevir or telaprevir for non-cirrhotic patients with chronic hepatitis C virus genotype 1b infectionEiichi Ogawa, Norihiro Furusyo, Eiji Kajiwara, et al.Journal of Gastroenterology and Hepatology|March 18, 2015
Comparative safety study on severe anemia by simeprevir versus telaprevir-based triple therapy for chronic hepatitis CEiichi Ogawa, Norihiro Furusyo, Eiji Kajiwara, et al.World Journal of Gastroenterology|March 8, 2006
Interferon alpha plus ribavirin combination treatment of Japanese chronic hepatitis C patients with HCV genotype 2: a project of the Kyushu University Liver Disease Study GroupNorihiro Furusyo, Masaki Katoh, Yuichi Tanabe, et al.Atherosclerosis Plus|January 13, 2025
Impact of NAFLD-related SNPs on the carotid atherosclerosis development; a five-year prospective observational studyHiroaki Ikezaki, Ryoko Nakashima, Yuji Matsumoto, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 28, 2012
An inadequate dose of ribavirin is related to virological relapse by chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirinEiichi Ogawa, Norihiro Furusyo, Eiji Kajiwara, et al.Journal of Hepatology|May 28, 2013
Clinical milestones for the prediction of severe anemia by chronic hepatitis C patients receiving telaprevir-based triple therapyEiichi Ogawa, Norihiro Furusyo, Makoto Nakamuta, et al.Pageof 20